Naomi Kawashima, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 11 | 2024 | 3602 | 1.650 |
Why?
|
fms-Like Tyrosine Kinase 3 | 4 | 2024 | 495 | 1.000 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 3 | 2024 | 351 | 0.730 |
Why?
|
Hematopoietic Stem Cell Transplantation | 8 | 2021 | 5649 | 0.720 |
Why?
|
DNA Repeat Expansion | 1 | 2020 | 72 | 0.690 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2018 | 228 | 0.610 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2018 | 452 | 0.550 |
Why?
|
Donor Selection | 1 | 2018 | 228 | 0.520 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2018 | 646 | 0.490 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2018 | 1596 | 0.440 |
Why?
|
Thrombocythemia, Essential | 2 | 2024 | 107 | 0.430 |
Why?
|
Translocation, Genetic | 1 | 2018 | 1388 | 0.420 |
Why?
|
Hematologic Neoplasms | 3 | 2018 | 1895 | 0.380 |
Why?
|
Mutation | 8 | 2024 | 29932 | 0.360 |
Why?
|
Tissue and Organ Procurement | 1 | 2018 | 944 | 0.340 |
Why?
|
Repressor Proteins | 2 | 2024 | 2981 | 0.320 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 2 | 2017 | 263 | 0.240 |
Why?
|
Leukemia, Large Granular Lymphocytic | 1 | 2024 | 24 | 0.240 |
Why?
|
Janus Kinase 2 | 2 | 2024 | 542 | 0.230 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2024 | 95 | 0.220 |
Why?
|
DNA-Binding Proteins | 3 | 2024 | 9585 | 0.220 |
Why?
|
Calreticulin | 1 | 2024 | 115 | 0.210 |
Why?
|
Receptors, Thrombopoietin | 1 | 2024 | 161 | 0.210 |
Why?
|
Transplantation, Homologous | 3 | 2020 | 4810 | 0.200 |
Why?
|
Magnolia | 1 | 2019 | 3 | 0.170 |
Why?
|
Neoplasms, Second Primary | 2 | 2018 | 1056 | 0.170 |
Why?
|
Hematologic Diseases | 2 | 2021 | 496 | 0.170 |
Why?
|
Transcription Factors | 1 | 2018 | 12103 | 0.160 |
Why?
|
Clone Cells | 1 | 2022 | 1660 | 0.150 |
Why?
|
Myelodysplastic-Myeloproliferative Diseases | 1 | 2018 | 15 | 0.150 |
Why?
|
Myeloproliferative Disorders | 1 | 2024 | 609 | 0.150 |
Why?
|
Photopheresis | 1 | 2018 | 35 | 0.150 |
Why?
|
Gene Frequency | 1 | 2024 | 3615 | 0.150 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2018 | 251 | 0.140 |
Why?
|
Japan | 2 | 2018 | 1369 | 0.140 |
Why?
|
Chimerism | 1 | 2017 | 155 | 0.140 |
Why?
|
Adolescent | 10 | 2024 | 87810 | 0.130 |
Why?
|
Germ-Line Mutation | 1 | 2024 | 1841 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2020 | 727 | 0.130 |
Why?
|
Iodine | 1 | 2018 | 286 | 0.130 |
Why?
|
Tretinoin | 1 | 2018 | 519 | 0.130 |
Why?
|
Survival Rate | 3 | 2018 | 12808 | 0.120 |
Why?
|
Graft vs Host Disease | 2 | 2018 | 3025 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 698 | 0.120 |
Why?
|
Young Adult | 8 | 2024 | 58741 | 0.120 |
Why?
|
Busulfan | 1 | 2015 | 258 | 0.120 |
Why?
|
Bone Marrow Cells | 1 | 2022 | 2414 | 0.120 |
Why?
|
Remission Induction | 1 | 2020 | 2392 | 0.120 |
Why?
|
Middle Aged | 16 | 2024 | 220352 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 2 | 2021 | 5643 | 0.110 |
Why?
|
Bacteremia | 1 | 2021 | 980 | 0.110 |
Why?
|
Staining and Labeling | 1 | 2018 | 1089 | 0.110 |
Why?
|
Alleles | 1 | 2024 | 6898 | 0.110 |
Why?
|
Waiting Lists | 1 | 2018 | 763 | 0.110 |
Why?
|
Adult | 14 | 2024 | 219994 | 0.100 |
Why?
|
Transplantation Conditioning | 2 | 2017 | 1588 | 0.100 |
Why?
|
Aged | 11 | 2024 | 169152 | 0.090 |
Why?
|
Male | 17 | 2024 | 359744 | 0.090 |
Why?
|
Female | 18 | 2024 | 391270 | 0.090 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6828 | 0.090 |
Why?
|
Humans | 24 | 2024 | 760621 | 0.090 |
Why?
|
Thrombosis | 1 | 2024 | 3052 | 0.090 |
Why?
|
HLA Antigens | 1 | 2015 | 1368 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6544 | 0.080 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4107 | 0.080 |
Why?
|
Cyclophosphamide | 1 | 2015 | 2221 | 0.080 |
Why?
|
Dioxygenases | 2 | 2024 | 335 | 0.080 |
Why?
|
Anticoagulants | 1 | 2024 | 4897 | 0.080 |
Why?
|
Recurrence | 1 | 2021 | 8482 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8552 | 0.080 |
Why?
|
Disease Progression | 3 | 2024 | 13502 | 0.080 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1648 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2019 | 5253 | 0.070 |
Why?
|
Sequence Deletion | 2 | 2019 | 1493 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6479 | 0.060 |
Why?
|
Graft Rejection | 1 | 2017 | 4426 | 0.060 |
Why?
|
Genetic Variation | 1 | 2019 | 6551 | 0.060 |
Why?
|
Time Factors | 4 | 2018 | 40165 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2020 | 65017 | 0.060 |
Why?
|
Point Mutation | 2 | 2019 | 1594 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3323 | 0.060 |
Why?
|
Anemia, Hemolytic | 1 | 2024 | 163 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2022 | 18137 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 29658 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2024 | 58995 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8469 | 0.050 |
Why?
|
Bacillus cereus | 1 | 2021 | 36 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2024 | 2919 | 0.050 |
Why?
|
GTP Phosphohydrolases | 1 | 2024 | 518 | 0.050 |
Why?
|
Segmental Duplications, Genomic | 1 | 2019 | 19 | 0.040 |
Why?
|
Core Binding Factor beta Subunit | 1 | 2020 | 42 | 0.040 |
Why?
|
DNA, Chloroplast | 1 | 2019 | 5 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2024 | 80372 | 0.040 |
Why?
|
Phylogeography | 1 | 2019 | 72 | 0.040 |
Why?
|
Plant Leaves | 1 | 2019 | 151 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2018 | 2418 | 0.040 |
Why?
|
Myosin Heavy Chains | 1 | 2020 | 402 | 0.040 |
Why?
|
Prebiotics | 1 | 2018 | 41 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2018 | 363 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2018 | 79 | 0.040 |
Why?
|
Founder Effect | 1 | 2018 | 186 | 0.040 |
Why?
|
Graft vs Leukemia Effect | 1 | 2017 | 121 | 0.040 |
Why?
|
Philadelphia Chromosome | 1 | 2017 | 117 | 0.040 |
Why?
|
Spliceosomes | 1 | 2018 | 129 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2019 | 786 | 0.040 |
Why?
|
Lymphocyte Transfusion | 1 | 2017 | 232 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17790 | 0.030 |
Why?
|
GPI-Linked Proteins | 1 | 2017 | 468 | 0.030 |
Why?
|
Antilymphocyte Serum | 1 | 2017 | 482 | 0.030 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2017 | 431 | 0.030 |
Why?
|
Ecosystem | 1 | 2019 | 485 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2024 | 16939 | 0.030 |
Why?
|
Mice | 1 | 2022 | 81208 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 22072 | 0.030 |
Why?
|
Anemia | 1 | 2024 | 1511 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2024 | 2828 | 0.030 |
Why?
|
Tacrolimus | 1 | 2017 | 733 | 0.030 |
Why?
|
Biological Evolution | 1 | 2019 | 1074 | 0.030 |
Why?
|
Child | 2 | 2018 | 79806 | 0.030 |
Why?
|
Prospective Studies | 4 | 2020 | 54303 | 0.030 |
Why?
|
Chronic Disease | 2 | 2018 | 9287 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2017 | 1007 | 0.030 |
Why?
|
Drug Resistance | 1 | 2018 | 1617 | 0.030 |
Why?
|
Phylogeny | 1 | 2019 | 2775 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2913 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4573 | 0.020 |
Why?
|
Proteomics | 1 | 2024 | 3817 | 0.020 |
Why?
|
Animals | 1 | 2022 | 167963 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39261 | 0.020 |
Why?
|
Leukocytes | 1 | 2017 | 2026 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2145 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2024 | 7850 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2017 | 5201 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 4490 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10182 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4166 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3758 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11071 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8056 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8515 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7408 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9411 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23376 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36060 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42063 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13630 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74359 | 0.010 |
Why?
|